The buildings are being purchased "to support the company’s manufacturing operations for rilparencel, the company’s lead ...

US packaging giant backing huge demand for injectable obesity drugs to fill the gap left by falling demand for Covid vaccines ...

Novonix has made meaningful strides towards bringing its Chattanooga facility to production. The company has lined up ...

Another milestone has been reached for a next-generation nuclear reactor in Oak Ridge. The U.S. Nuclear Regulatory Commission ...

Companies like Google are thirsty for the clean energy that nuclear power produces. These two new ones will be built in ...

Embracing industrial symbiosis goes beyond ethical responsibility; it’s a chance for companies to lower costs, reduce ...

Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

Thermo Fisher has launched a suite of expanded CRO and CDMO services under its own brand, Accelerator™ Drug Development, intended to serve biotechs and pharmas.

A dose of four Wegovy injections will cost 1,400 yuan ($194), a fraction of the drug’s U.S. price, according to the Chinese ...

The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...

A short strangle on Eli Lilly will generate $1,125 in option premium and takes advantage of the current high level of implied ...

A lab-grown alternative to fattened duck liver offers a controversial future for the cultivated meat industry: as a luxury ...